Approximately 18 million Americans suffer from Obstructive Sleep Apnea (OSA). A common prescribed treatment for OSA is CPAP (Continuous Positive Airway Pressure) which requires the use of a face mask, hose and continuous flow of pressure for treatment.
The question is, how many OSA patients are using their CPAP? One study shows that between 30-50 percent of OSA patients fail to use their CPAP machine, following an approximated 50 percent abandoning their CPAPs within 1-3 weeks of use. Untreated OSA can result in many profound consequences, such as fatigue, increased risk of stroke, heart problems and diabetes.
For those patients, unable to tolerate their CPAP or travel frequently, there is now a simple, compact and FDA cleared alternative! Research shows that PROVENT Therapy is comparable to CPAP for treating mild to moderate OSA, and can improve severe OSA by an estimated 60%.
Receive information on
becoming a supplier.
Provent is distributed by Barber Holding LLC